CXCL12 and breast cancer: Src is responsible for mediating breast cancer cell survival in the bone marrow, by controlling tumour cell response to both pro-survival signals in the bone microenvironment like CXCL12 and by conferring resistance to pro-apoptotic signals such as TRAIL (Zhang et al. 2009).